Main Article Content
Use of cardiovascular implantable electronic devices (CIED) has been increasing exponentially in the last two decades and is a critical component in the management of patients with cardiac rhythm disturbances, heart failure and prevention of sudden death. Patients receiving CIED therapy are now older and have significant morbidities that have led to a disproportionate rise in device infections. Infection clearly reduces survival, carry high financial costs and is a challenging infective process that require expert multidisciplinary teams for an adequate management. Moreover, some aspects of diagnosis, treatment and prevention are still conflictive and a matter of debate. This review provides a comprehensive examination of several aspects, with a critical revision of the supporting evidences.
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.